ClinicalTrials.gg
CompletedNCT07772193PDGT-PPUUpdated Aug 21, 2026

Short-Term Psychodynamic Group Therapy for Problematic Pornography Use

An interventional study of Short-Term Psychodynamic Group Therapy in Addiction, sponsored by Harun Ismail Incekara. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Harun Ismail Incekara · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Dec 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

This randomized controlled trial evaluated the effects of short-term psychodynamic group therapy for problematic pornography use in young adult men. Participants were assigned to either a psychodynamic group therapy intervention or a control condition. The intervention consisted of 16 online group therapy sessions. The study examined changes in pornography craving, emotion regulation difficulties, shame, and guilt. Assessments were conducted before and after the intervention and at follow-up.

02

Conditions studied

  • Addiction

Browse trials for

Keywords

  • Problematic Pornography Use
  • Pornography Craving
  • Psychodynamic Psychotherapy
  • group Psychotherapy
03

In context

Behavior, Addictive

521 studies on the registry are indexed under Behavior, Addictive; 124 are open to participants now.

This study's enrollment of 30 is below the median of 62 across 399 interventional studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

This is the only study on the registry with Harun Ismail Incekara as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male sex
  • Aged 18-30 years
  • At least a high school education
  • Pornography use on at least 3 days per week
  • Meeting the study's screening criterion for problematic pornography use
  • Providing and willingness to participate in the intervention and assessments

Exclusion criteria

Exclusion Criteria:

  • Self-reported history of a severe psychiatric disorder
  • Self-reported history of substance dependence
  • Severe psychological distress requiring individual psychiatric intervention
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Psychodynamic Group Therapy

    Participants assigned to this arm received short-term psychodynamic group therapy consisting of 16 online group sessions.

    Behavioral: Short-Term Psychodynamic Group Therapy

  • No intervention
    Control Group

    Participants assigned to this arm did not receive the psychodynamic group therapy intervention during the study period.

Interventions

  • BehavioralShort-Term Psychodynamic Group Therapy

    The intervention consisted of 16 online psychodynamic group therapy sessions, each lasting approximately 90 minutes. Sessions were conducted in a group format via Google Meet. The intervention focused on psychodynamic exploration of problematic pornography use, including associated emotions, interpersonal patterns, internal conflicts, and difficulties in emotion regulation.

06

What researchers measure

Primary outcomes

  1. Pornography Craving Questionnaire (PCQ) Score

    Pornography craving was assessed using the Pornography Craving Questionnaire (PCQ). Higher scores indicate greater pornography craving.

    Time frame: Baseline, Week 8, and 3-month follow-up

Secondary outcomes

  1. Difficulties in Emotion Regulation Scale-16 (DERS-16) Score

    The Difficulties in Emotion Regulation Scale-16 (DERS-16) was used to assess difficulties in emotion regulation. The scale consists of 16 items rated from 1 to 5, yielding a total score ranging from 16 to 80. Higher scores indicate greater difficulties in emotion regulation and therefore a worse outcome.

    Time frame: Baseline, Week 8, and 3-month follow-up

  2. Trait Shame and Guilt Scale - Shame Subscale Score

    Shame was assessed using the shame subscale of the Trait Shame and Guilt Scale (TSGS). The mean subscale score ranges from 1 to 5, with higher scores indicating greater levels of shame and therefore a worse outcome.

    Time frame: Baseline, Week 8, and 3-month follow-up

07

Study locations

1 site
  • Medipol University
    Istanbul, Istanbul 34142, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to the sensitive nature of the data and participant confidentiality considerations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Apr 2026, 4 months.

Of 147 non-industry interventional studies with no phase under Behavior, Addictive, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 42. This study's 4 months is below that.

Counting every sponsor, half of 155 studies reached it within 26 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2026
First posted
Aug 19, 2026
StartActual
Dec 1, 2025
Primary completionActual
Apr 1, 2026
CompletionActual
May 1, 2026
Last update
Aug 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07772193
Lead sponsor
Harun Ismail Incekara
Responsible party
Harun Ismail Incekara (Principal Investigator, Medipol University) — Sponsor-investigator
First posted
Aug 19, 2026
Start date
Dec 1, 2025
Primary completion
Apr 1, 2026
Completion
May 1, 2026
Last update
Aug 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion